|
|
||||||||
From the Departments of Pediatrics (Drs. Asano, D.C. Chugani, Juhász, and H.T. Chugani), Radiology (Drs. D.C. Chugani, Muzik, and H.T. Chugani, and C. Shen), Neurosurgery (Dr. Canady), and Neurology (Drs. J.R. Shah, A.K. Shah, Watson, and H.T. Chugani), and the Center for Health Effectiveness Research (Dr. Ager and J. Janisse), Childrens Hospital of Michigan and Detroit Medical Center, Wayne State University School of Medicine.
Address correspondence and reprint requests to Dr. Diane C. Chugani, PET Center, Childrens Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI 48201.
OBJECTIVE: Using interictal
-[11C]methyl-L-tryptophan ([11C]AMT) PET scan, the authors have undertaken a quantitative analysis of all tubers visible on MRI or 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET, to determine the relationship between [11C]AMT uptake and epileptic activity on EEG.
BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominant disorder, often associated with cortical tubers and intractable epilepsy. The authors have shown previously that [11C]AMT PET scans show high tracer uptake in some epileptogenic tubers and low uptake in the remaining tubers.
METHODS: Eighteen children, age 7 months to 16 years, were studied. Patients underwent video-EEG monitoring, PET scans of [11C]AMT and [18F]FDG, and T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI. [11C]AMT uptake values were measured in 258 cortical tubers delineated with coregistered MRI or [18F]FDG scans. Uptake ratios were calculated between the [11C]AMT uptake in tubers and those for normal cortex (tuber/normal cortex). Using the region of epileptiform activity, the authors performed receiver operator characteristics (ROC) analysis and determined the optimal uptake ratio for detecting presumed epileptogenic tubers.
RESULTS: Tuber uptake ratios ranged from 0.6 to 2.0. Tuber uptake ratios in the epileptic lobes were higher than those in the nonepileptic lobes (p < 0.0001). All 15 patients with focal seizure activity showed one or more lesions with uptake ratio above 0.98 in the epileptic lobe. ROC analysis showed that a tuber uptake ratio of 0.98 resulted in a specificity of 0.91.
CONCLUSIONS: Cortical tubers with [11C]AMT uptake greater than or equal to normal cortex are significantly related to epileptiform activity in that lobe. Together, interictal [11C]AMT PET and FLAIR MRI improve the detection of potentially epileptogenic tubers in patients with TSC being evaluated for epilepsy surgery.
Key words: Tuberous sclerosis complexPET
-[11C]methyl-L-tryptophanSerotoninEpilepsy surgeryNeuroimagingQuinolinic acid.
This article has been cited by other articles:
![]() |
T. J. Eluvathingal, M. E. Behen, H. T. Chugani, J. Janisse, B. Bernardi, P. Chakraborty, C. Juhasz, O. Muzik, and D. C. Chugani Cerebellar Lesions in Tuberous Sclerosis Complex: Neurobehavioral and Neuroimaging Correlates J Child Neurol, October 1, 2006; 21(10): 846 - 851. [Abstract] [PDF] |
||||
![]() |
H. L. Weiner, C. Carlson, E. B. Ridgway, C. M. Zaroff, D. Miles, J. LaJoie, and O. Devinsky Epilepsy Surgery in Young Children With Tuberous Sclerosis: Results of a Novel Approach Pediatrics, May 1, 2006; 117(5): 1494 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kagawa, D. C. Chugani, E. Asano, C. Juhasz, O. Muzik, A. Shah, J. Shah, S. Sood, W. J. Kupsky, T. J. Mangner, et al. Epilepsy Surgery Outcome in Children With Tuberous Sclerosis Complex Evaluated With {alpha}-[11C]Methyl-L-Tryptophan Positron Emission Tomography (PET) J Child Neurol, May 1, 2005; 20(5): 429 - 438. [Abstract] [PDF] |
||||
![]() |
P. Curatolo, R. Bombardieri, M. Verdecchia, and S. Seri Topical Review: Intractable Seizures in Tuberous Sclerosis Complex: From Molecular Pathogenesis to the Rationale for Treatment J Child Neurol, April 1, 2005; 20(4): 318 - 325. [Abstract] [PDF] |
||||
![]() |
K. Ridler, J. Suckling, N. Higgins, P. Bolton, and E. Bullmore Standardized Whole Brain Mapping of Tubers and Subependymal Nodules in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 658 - 665. [Abstract] [PDF] |
||||
![]() |
E. A. Thiele Managing Epilepsy in Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 680 - 686. [Abstract] [PDF] |
||||
![]() |
P. Curatolo, R. Bombardieri, M. Verdecchia, and S. Seri Topical Review: Intractable Seizures in Tuberous Sclerosis Complex: From Molecular Pathogenesis to the Rationale for Treatment J Child Neurol, March 1, 2004; 19(3): 318 - 325. [Abstract] [PDF] |
||||
![]() |
C. Juhasz, D.C. Chugani, O. Muzik, A. Shah, E. Asano, T.J. Mangner, P.K. Chakraborty, S. Sood, and H.T. Chugani Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy Neurology, March 25, 2003; 60(6): 960 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asano, D. C. Chugani, O. Muzik, M. Behen, J. Janisse, R. Rothermel, T. J. Mangner, P. K. Chakraborty, and H. T. Chugani Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction Neurology, October 9, 2001; 57(7): 1269 - 1277. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |